Recombinant Bacillus subtilis Uncharacterized protein ypmT (ypmT)

Shipped with Ice Packs
In Stock

Description

Molecular Characterization

Amino Acid Sequence:
The full-length protein consists of 64 amino acids with the sequence:
MKRIYQYFSLLSFTFSLYFGWLAYHHLAAEDMDQMYLNVSYCALFLSVMVFTFGMRDRKK TDKS .

Physical Properties:

PropertyValue/DescriptionSource
Molecular Weight~7.6 kDa (calculated)
TagN-terminal 10×His tag
Isoelectric Point (pI)Predicted 9.3 (uncharacterized experimentally)
UniProt IDP54180

Expression Systems and Production

Recombinant ypmT is typically produced in E. coli expression systems due to their scalability and cost-effectiveness . Key parameters include:

  • Induction: Requires IPTG (isopropyl β-D-1-thiogalactopyranoside) for transcriptional activation under T7/lac promoters .

  • Secretion: Utilizes Sec-dependent pathways for extracellular export, though cytoplasmic retention is common in E. coli systems .

  • Yield: Production levels vary based on host strain and culture conditions, with purity exceeding 80–90% post-affinity chromatography .

Purification and Quality Control

Chromatography:

  • Immobilized Metal Affinity Chromatography (IMAC): Leverages the His-tag for nickel- or cobalt-based resin purification .

  • Buffer Composition: Tris/PBS-based buffers with 6% trehalose for stability during lyophilization .

Quality Metrics:

ParameterSpecification
Purity>80% by SDS-PAGE
Endotoxin Levels<1.0 EU/μg (LAL assay)
Storage Stability-80°C for long-term; 4°C for ≤1 week

Research Applications

  • Structural Biology: Serves as a model for studying small, hydrophobic bacterial proteins with potential membrane association .

  • Biotechnological Tool: Used in amber suppression systems for site-specific incorporation of non-canonical amino acids .

  • Host Compatibility Testing: Validates B. subtilis secretion pathways for industrial enzyme production .

Challenges and Future Directions

While B. subtilis is a GRAS (Generally Recognized As Safe) organism with robust secretion pathways , recombinant ypmT production faces limitations:

  • Low Solubility: Hydrophobic regions necessitate detergent screening for in vitro studies .

  • Functional Annotation: Computational predictions suggest transmembrane domains, but experimental validation is pending .

Future work should prioritize structural elucidation (e.g., X-ray crystallography) and genetic knockout studies to define ypmT’s role in B. subtilis physiology .

Product Specs

Form
Lyophilized powder
Note: While we will prioritize shipping the format currently in stock, we understand you may have specific requirements. If so, please indicate your preferred format in the order notes, and we will accommodate your request to the best of our ability.
Lead Time
Delivery times can vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All of our proteins are shipped standard with blue ice packs. If dry ice shipping is required, please notify us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal results, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial before opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration between 0.1 and 1.0 mg/mL. To enhance long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting the solution for storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference point.
Shelf Life
The shelf life of our proteins is influenced by several factors, including storage conditions, buffer components, temperature, and the protein's inherent stability.
Generally, liquid forms have a shelf life of 6 months when stored at -20°C/-80°C. Lyophilized forms have a shelf life of 12 months when stored at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot the protein for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process.
If you have a specific tag type in mind, please inform us, and we will prioritize its development during production.
Synonyms
ypmT; BSU21720; Uncharacterized protein YpmT
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-64
Protein Length
full length protein
Species
Bacillus subtilis (strain 168)
Target Names
ypmT
Target Protein Sequence
MKRIYQYFSLLSFTFSLYFGWLAYHHLAAEDMDQMYLNVSYCALFLSVMVFTFGMRDRKK TDKS
Uniprot No.

Target Background

Database Links
Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What expression systems are most effective for studying uncharacterized proteins like ypmT in Bacillus subtilis?

B. subtilis offers several robust expression systems for recombinant protein production. For uncharacterized proteins, the pHT43 plasmid system has demonstrated success in expressing fusion proteins with clear visualization via Western blotting . This shuttle vector allows for IPTG-inducible expression, which is valuable for controlling protein production levels. Typically, expression can be induced when bacterial cultures reach OD₆₀₀ = 0.5 using 0.1M IPTG, followed by continued culture for approximately 3 hours . The system's effectiveness is evidenced by successful expression of recombinant proteins showing clear positive bands at expected molecular weights during Western blot analysis with appropriate antibodies .

What growth conditions are optimal when working with recombinant B. subtilis strains expressing novel proteins?

For optimal growth of recombinant B. subtilis strains, LB medium supplemented with appropriate antibiotics for selection is typically used. Based on experimental protocols with various B. subtilis strains, including those with multiple gene deletions, supplementing LB medium with 1% glucose and 10 mM Mg²⁺ has shown to improve growth rates in strains with potential metabolic burdens . Cultures are typically maintained at 37°C with 200 RPM shaking . For strains expressing proteins under inducible promoters, careful monitoring of culture density before induction is crucial, with OD₆₀₀ = 0.5 being a common induction point . Post-collection processing typically involves washing the cells three times with PBS before proceeding to protein extraction via ultrasonication .

How can I verify successful expression of an uncharacterized protein like ypmT in B. subtilis?

Verification of uncharacterized protein expression requires a multi-step approach:

  • Western blotting: If antibodies against the target protein are unavailable (common with uncharacterized proteins), fusion tags (His, FLAG, etc.) can be incorporated into the expression construct. Proteins can then be detected using commercial antibodies against these tags .

  • Protein size verification: Clear, positive bands at the expected molecular weight provide initial confirmation of successful protein expression . Super ECL Plus systems offer enhanced visualization of protein bands, which is particularly useful for proteins expressed at lower levels .

  • Functional assays: For proteins with predicted functions, activity assays provide functional verification. For instance, if ypmT were predicted to be RNA-binding (similar to YlxR/RnpM), RNA binding assays could confirm functional expression .

  • Mass spectrometry: For definitive identification, peptide mass fingerprinting can confirm the expression of the target protein even without specific antibodies.

What transformation methods are most efficient for introducing recombinant constructs into B. subtilis for uncharacterized protein studies?

B. subtilis offers natural genetic transformation abilities, making it an excellent host for genetic manipulation. Two primary methods have demonstrated high efficiency:

  • Electroporation: This method has proven effective for transforming plasmids such as pHT43-based constructs into B. subtilis strains like WB800N . Electroporation parameters should be optimized for the specific strain, but typically use field strengths of 1.5-2.5 kV/cm.

  • Natural competence-based transformation: This method is particularly effective when using chromosomal DNA rather than plasmid DNA, as chromosomal DNA integrates with significantly higher efficiency . An optimized protocol involves:

    • Growing cells to mid-exponential phase

    • Diluting to an OD₆₀₀ of 0.1

    • Preparing competent cells according to established protocols

For strains with cell division defects that might affect transformation efficiency, the chromosomal DNA approach is particularly valuable . When combining multiple genomic mutations, marker-less gene deletion methods utilizing tools like the IPTG-inducible mazF toxin cassette can circumvent limitations in available antibiotic resistance markers .

What computational approaches are most effective for predicting functions of uncharacterized proteins like ypmT in B. subtilis?

Computational characterization should employ multiple complementary approaches:

  • Homology modeling: The SWISS-MODEL pipeline can construct structural models based on homologous proteins with known structures . This approach has successfully identified potential functions for previously uncharacterized proteins by revealing structural similarities to characterized proteins.

  • Motif search and binding site prediction: Tools like the MEME software suite (with E-value thresholds of <1e-3) can identify potential DNA binding motifs for proteins predicted to be transcription factors . This approach would be relevant if ypmT were predicted to have DNA-binding properties.

  • Functional enrichment analysis: Categorizing potential regulon genes according to clusters of orthologous groups (COG) categories and performing hypergeometric tests (with P-value thresholds of <0.01) can reveal statistically significant functional enrichments . This approach helps place the uncharacterized protein within cellular pathways.

  • Oligomeric state inference: Analysis of interface conservation scores compared to existing complexes with similar sequence identity can provide insights into potential protein-protein interactions , which is crucial for understanding protein function within cellular networks.

How can RNA-binding capability of uncharacterized proteins like ypmT be effectively assessed in B. subtilis?

If ypmT is predicted to have RNA-binding properties (similar to YlxR/RnpM), several approaches can be employed:

  • RNA partner identification: Methods similar to those used to identify YlxR's binding to P RNA can be applied to detect RNA interaction partners . This involves RNA immunoprecipitation followed by sequencing (RIP-seq) to identify enriched RNA species.

  • Functional impact assessment: Once an RNA partner is identified, in vitro processing assays can determine whether the protein modulates RNA function . For example, YlxR was shown to reduce RNase P activity through such assessments.

  • Structural characterization: Chemical cross-linking studies followed by mass spectrometry can identify the specific binding interface between the protein and its RNA partner . This information can be complemented with in silico modeling to create a comprehensive structural understanding of the ribonucleoprotein complex.

  • Site-directed mutagenesis: Based on structural predictions, key residues involved in RNA binding can be mutated to confirm their functional importance , providing experimental validation of computational predictions.

What strategies can be employed to establish the minimal set of interacting partners for an uncharacterized protein like ypmT in B. subtilis?

Establishing a protein's interaction network requires systematic approaches:

  • Sequential gene deletion strategy: A methodology similar to that used to define the minimal divisome in B. subtilis can be applied . This involves:

    • Creating marker-less gene deletions using recombination-based methods like the IPTG-inducible mazF toxin cassette

    • Sequential removal of potential interaction partners

    • Phenotypic assessment after each deletion to identify essential interactions

  • Synthetic genetic arrays: Systematically combining a ypmT deletion with deletions of other genes can reveal genetic interactions through growth phenotypes.

  • Pull-down assays coupled with mass spectrometry: Tagging ypmT with an affinity tag allows purification of protein complexes, which can then be identified through mass spectrometry.

  • Bacterial two-hybrid systems: These can screen for direct protein-protein interactions between ypmT and candidate partners.

Each approach provides complementary information, with physical interaction methods (pull-downs, two-hybrid) identifying direct partners while genetic approaches (deletions, synthetic arrays) reveal functional relationships that may include indirect interactions.

How can differential expression analysis be optimized to understand the regulatory impact of uncharacterized proteins like ypmT?

For robust differential expression analysis:

  • Statistical rigor: Implement the Wald test for calculating P-values from filtered gene subsets, with adjustment for multiple testing using the Benjamini and Hochberg procedure . Consider expression changes significant when they meet dual criteria: log₂(fold-change) ≥ log₂(2.0) and adjusted P-value <0.05 (or log₂(fold-change) ≤ -log₂(2.0) and adjusted P-value <0.05) .

  • ChIP-exo for binding site identification: This technique provides high-resolution mapping of protein-DNA interactions, which is particularly valuable for potential transcription factors . It allows precise identification of binding motifs and regulated genes.

  • Integration of multiple data types: Combine transcriptomic data with ChIP-exo binding data and functional enrichment analysis to create a comprehensive understanding of the protein's regulatory role .

  • Time-course analysis: Rather than single time-point measurements, monitoring expression changes over time following induction or deletion of the uncharacterized protein provides greater insight into direct versus indirect regulatory effects.

What are the most effective approaches for assessing the impact of uncharacterized proteins like ypmT on specific cellular pathways in B. subtilis?

Pathway-specific analysis requires targeted methodologies:

  • Phenotypic microarrays: These can systematically test growth across hundreds of different conditions to identify specific metabolic or stress response pathways affected by protein deletion or overexpression.

  • Metabolomic profiling: Comparing metabolite levels between wild-type and mutant strains can reveal metabolic pathways impacted by the protein of interest.

  • Pathway-specific reporter systems: Constructing fluorescent or luminescent reporters driven by promoters of key pathway genes can provide real-time monitoring of pathway activity.

  • Specific growth challenges: Based on computational predictions, targeted growth experiments under conditions that stress specific pathways (e.g., nutrient limitation, oxidative stress) can reveal conditional phenotypes . These can be quantified through growth curve measurements in microtiter plates, starting with overnight cultures from fresh colonies, diluted to an OD₆₀₀ of 0.1, grown to mid-exponential phase, and further diluted to an OD₆₀₀ of 0.05 for precise monitoring .

How can one develop effective mucosal delivery systems using B. subtilis expressing uncharacterized proteins of interest?

If ypmT has potential as a component in mucosal vaccine delivery systems:

  • Fusion protein design: Creation of fusion proteins combining ypmT with antigens of interest, similar to approaches used with PEDV COE region proteins . This may require structural modeling to determine optimal fusion points that maintain protein function.

  • M-cell targeting enhancement: Incorporation of molecules like L-Lectin-β-GF that enhance binding to M cells can improve mucosal immunity by increasing antigen delivery to gut-associated lymphoid tissue . Ligated loop experiments in animal models can confirm localization to M cells, with quantitative assessment of bacterial presence in follicular-associated epithelium (FAE) .

  • Immune response evaluation: Assessment of both mucosal and systemic immune responses through:

    • Measurement of antigen-specific secretory IgA (sIgA) in intestinal wash samples

    • Quantification of serum antibody titers for systemic immunity

    • Analysis of T cell populations (CD3+/CD4+ and CD3+/CD8+) in mesenteric lymph nodes and spleen lymphocytes using flow cytometry

  • Stability optimization: Development of spore-based delivery systems that protect the recombinant protein through the harsh gastric environment, with controlled germination in the intestinal tract.

How can researchers effectively design experiments to distinguish between direct and indirect effects of uncharacterized proteins like ypmT?

Distinguishing direct from indirect effects requires careful experimental design:

  • Inducible expression systems: Utilizing IPTG-inducible systems allows time-course studies following protein induction, with early changes more likely representing direct effects .

  • Complementation studies: Creating complementation strains where the wild-type protein is reintroduced can confirm phenotype specificity and rule out polar effects.

  • Protein-binding studies: Direct binding targets can be identified through techniques like ChIP-exo for DNA-binding proteins or RNA immunoprecipitation for RNA-binding proteins . These direct binding events can then be correlated with functional effects.

  • Mutation of binding domains: Creating variants with mutations in predicted binding domains can help separate direct binding-dependent effects from other protein functions.

  • Rapid induction systems: For kinetic discrimination, systems allowing rapid protein induction combined with time-series sampling can reveal the temporal order of effects, with primary effects occurring before secondary consequences.

What approaches can overcome the challenges in studying proteins with dual or multiple functions in B. subtilis?

Multifunctional proteins require specialized approaches:

  • Domain-specific mutations: Creating variants with mutations in specific functional domains can help dissect individual functions without disrupting the entire protein.

  • Conditional expression of functional domains: Expressing individual domains of the protein can help attribute specific functions to particular regions.

  • Integration of multiple data types: Combining structural, genetic, biochemical, and physiological data provides a more complete picture of multifunctional proteins. For example, the YlxR/RnpM protein was found to bind to P RNA and modulate RNase P activity through an integrated approach combining binding studies, functional assays, and structural modeling .

  • Interactome analysis under different conditions: Since multifunctional proteins may interact with different partners depending on cellular conditions, performing interaction studies under various conditions can reveal context-dependent functions.

  • Evolutionary analysis: Comparing protein conservation across species can identify highly conserved regions likely critical for core functions versus more variable regions that may confer species-specific secondary functions. This is particularly relevant for proteins like YlxR/RnpM that are widely conserved in bacteria, suggesting important functions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.